Being suitable for intravenous administration to object the invention discloses therapeutic formulation includes: aqueous solution A kind of hydrophobic active agent dispersion stable agent With the reducing agent of an opsonic action Wherein hydrophobic active agent is Co-Q10 (CoQ10) The wherein dispersion stabilizer Dimyristoylphosphatidyl choline (DMPC) The average particle size that wherein hydrophobic active agent colloidal Nanodispersion is dispersed into is in about 10-nm and about 100-nm.